Effect of Type-I Interferon on Retroviruses

被引:15
|
作者
Gomez-Lucia, Esperanza [1 ]
Collado, Victorio M. [1 ]
Miro, Guadalupe [1 ]
Domenech, Ana [1 ]
机构
[1] Univ Complutense, Dept Sanidad Anim, Fac Vet, E-28040 Madrid, Spain
来源
VIRUSES-BASEL | 2009年 / 1卷 / 03期
关键词
Type-I interferons; retrovirus; HIV-1; HTLV-I; FeLV; MuLV; ISRE; PLASMACYTOID DENDRITIC CELLS; FELINE IMMUNODEFICIENCY VIRUS; LONG TERMINAL REPEAT; MURINE LEUKEMIA-VIRUS; OVINE LENTIVIRUS REPLICATION; PRIMARY HIV-1 INFECTION; TOLL-LIKE-RECEPTORS; ALPHA-INTERFERON; IFN-ALPHA; T-CELLS;
D O I
10.3390/v1030545
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Type-I interferons (IFN-I) play an important role in the innate immune response to several retroviruses. They seem to be effective in controlling the in vivo infection, though many of the clinical signs of retroviral infection may be due to their continual presence which over-stimulates the immune system and activates apoptosis. IFN-I not only affect the immune system, but also operate directly on virus replication. Most data suggest that the in vitro treatment with IFN-I of retrovirus infected cells inhibits the final stages of virogenesis, avoiding the correct assembly of viral particles and their budding, even though the mechanism is not well understood. However, in some retroviruses IFN-I may also act at a previous stage as some retroviral LTRs posses sequences homologous to the IFN-stimulated response element (ISRE). When stimulated, ISREs control viral transcription. HIV-1 displays several mechanisms for evading IFN-I, such as through Tat and Nef. Besides IFN-alpha and IFN-beta, some other type I IFN, such as IFN-tau and IFN-omega, have potent antiviral activity and are promising treatment drugs.
引用
收藏
页码:545 / 573
页数:29
相关论文
共 50 条
  • [1] The effect of equine herpesvirus type 4 on type-I interferon signaling molecules
    Oladunni, Fatai S.
    Reedy, Stephanie
    Balasuriya, Udeni B. R.
    Horohov, David W.
    Chambers, Thomas M.
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2020, 219
  • [2] TYPE-I AND TYPE-II INTERFERON RECEPTORS
    ORCHANSKY, P
    NOVICK, D
    FISCHER, DG
    RUBINSTEIN, M
    JOURNAL OF INTERFERON RESEARCH, 1984, 4 (02): : 275 - 282
  • [3] Mechanisms of type-I interferon signal transduction
    Uddin, S
    Platanias, LC
    JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 37 (06): : 635 - 641
  • [4] Stochastic dynamics of Type-I interferon responses
    Maier, Benjamin D.
    Aguilera, Luis U.
    Sahle, Sven
    Mutz, Pascal
    Kalra, Priyata
    Daechert, Christopher
    Bartenschlager, Ralf
    Binder, Marco
    Kummer, Ursula
    PLOS COMPUTATIONAL BIOLOGY, 2022, 18 (10)
  • [5] Type-I Interferon Signaling in Fanconi Anemia
    Landelouci, Karima
    Sinha, Shruti
    Pepin, Genevieve
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [6] Dexamethasone inhibits type-i interferon receptor expression
    Renner, Eberhard L.
    Alphonse, Martin P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 578 - 578
  • [7] THE HUMAN TYPE-I INTERFERON GENE-CLUSTER
    DIAZ, MO
    SEMINARS IN VIROLOGY, 1995, 6 (03): : 143 - 149
  • [8] INTERFERON EXPRESSION IN THE PANCREASES OF PATIENTS WITH TYPE-I DIABETES
    HUANG, XJ
    YUAN, J
    GODDARD, A
    FOULIS, A
    JAMES, RFL
    LERNMARK, A
    PUJOLBORRELL, R
    RABINOVITCH, A
    SOMOZA, N
    STEWART, TA
    DIABETES, 1995, 44 (06) : 658 - 664
  • [9] THE EVOLUTION OF THE TYPE-I INTERFERON GENE FAMILY IN MAMMALS
    HUGHES, AL
    JOURNAL OF MOLECULAR EVOLUTION, 1995, 41 (05) : 539 - 548
  • [10] Does type-I interferon drive systemic autoimmunity?
    Picard, Cecile
    Belot, Alexandre
    AUTOIMMUNITY REVIEWS, 2017, 16 (09) : 897 - 902